We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inflammatory Response Kills Neurons in Alzheimer's Disease

By Biotechdaily staff writers
Posted on 19 May 2003
Researchers have identified a mechanism that causes microglial cells in the brain to secrete molecules that stimulate an inflammatory response against the amyloid plaques that are characteristic of Alzheimer's disease, which results in brain damage resulting from the death of neurons.

Investigators from Case Western Reserve University (Cleveland, OH, USA) reported in the April 2003 issue of the Journal of Neuroscience that the interaction of microglia with compacted deposits of amyloid fibrils resulted in the stimulation of intracellular Tyr kinase-based signaling cascades and cellular activation, which led to the secretion of pro-inflammatory molecules. More...


"When microglia undergo this activation, they secrete a large number of very nasty things,” explained senior author Dr. Gary Landreth, professor of neurosciences at Case Western Reserve University. "Over the long term, it is these inflammatory products of microglia that play a significant role in killing neurons. This fundamentally changes how people think about how the amyloid plaques provoke microglial activation. If we block any one of these receptors, we would block the inflammatory response. This presents new targets for new therapies to treat Alzheimer's disease.”




Related Links:
Case Western Reserve University

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.